DBD vs RPM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

DBD

45.3
AI Score
VS
DBD Wins

RPM

33.3
AI Score

Investment Advisor Scores

DBD

45score
Recommendation
HOLD

RPM

33score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric DBD RPM Winner
Forward P/E 12.6422 17.4825 DBD
PEG Ratio 0 1.7495 Tie
Revenue Growth 5.2% 4.8% DBD
Earnings Growth -82.9% 13.3% RPM
Tradestie Score 45.3/100 33.3/100 DBD
Profit Margin 2.0% 8.7% RPM
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY DBD

Relative Price Performance (Last 90 Days)

DBD 1M: -9.4% · 3M: -20.1% RPM 1M: +8.5% · 3M: -8.0%

Current Technical Phase

DBD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.9%), weak momentum, RSI 38

RSI (14): 38.3 · Price: $57.34

RPM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 57.0 · Price: $105.83

Fundamentals Snapshot

Metric DBD RPM
Market Cap — —
Forward P/E 9.3 18.0
Trailing P/E 28.5 19.7
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.3% 0.4%
Operating Margin 0.1% 0.2%
EPS 2.11 5.41
Dividend Yield — 0.02%

Frequently Asked Questions

Based on our detailed analysis, DBD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.